Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Avalon GloboCare ( (ALBT) ) is now available.
On February 12, 2026, Avalon GloboCare Corp. entered into a securities purchase agreement with Vanquish Funding Group, issuing a $233,910 promissory note for $207,000 in net proceeds, featuring a one-time 12% interest charge and maturing on February 15, 2027. The note, which carries stringent default provisions including a 150% payment of the default amount and a 25% discounted share-conversion feature capped at 19.99% of outstanding stock, provides working capital but introduces potential future equity dilution and heightened repayment obligations in the event of default.
The transaction closed on February 17, 2026, with Avalon paying a $10,000 cash fee to a placement agent and relying on private-offering exemptions under U.S. securities laws for the note issuance. Also on February 11, 2026, the company issued a total of 300,000 common shares to consultants as non-cash compensation for services rendered, further utilizing equity to fund operations without immediate cash inflows.
More about Avalon GloboCare
Avalon GloboCare Corp. operates in the healthcare and life sciences sector, focusing on developing and commercializing medical technologies and related services. The company accesses capital markets through structured financings and equity issuances to support its general working capital needs and ongoing corporate activities.
Average Trading Volume: 235,008
Technical Sentiment Signal: Sell
Current Market Cap: $4.01M
For detailed information about ALBT stock, go to TipRanks’ Stock Analysis page.